Luminex Corp (LMNX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7062
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP, xTAG and MultiCode. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Luminex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Luminex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Luminex Corp, Medical Equipment, Deal Details 10
Partnerships 10
Natural Molecular Testing Enters Into Licensing Agreement With Luminex 10
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 11
Genetic Analysis Enters into Agreement with Luminex 12
Luminex Enters into Distribution Agreement with Bio-Techne 13
Affymetrix Enters into Distribution Agreement with Luminex 14
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 15
Luminex Extends Distribution Agreement With EMD Millipore 16
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 17
Asset Transactions 18
Luminex Plans To Sell Newborn Screening Business 18
Acquisition 19
Luminex Acquires Nanosphere in Tender Offer 19
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto USD60 Million 21
Luminex Corp – Key Competitors 23
Luminex Corp – Key Employees 24
Luminex Corp – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Financial Announcements 27
Aug 06, 2018: Luminex reports second quarter 2018 financial results 27
May 07, 2018: Luminex Announces First Quarter 2018 Financial Results 28
Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 30
Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 31
May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 32
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 33
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 34
Product News 35
Oct 26, 2017: Vanderbilt Clinical Labs Choose VERIGENE Blood Culture Tests 35
Other Significant Developments 36
Aug 29, 2017: Luminex and Sutter Health Collaborate to Improve Patient Care 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Luminex Corp, Medical Equipment, Key Facts, 2017 2
Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Luminex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Luminex Corp, Deals By Market, 2012 to YTD 2018 8
Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Natural Molecular Testing Enters Into Licensing Agreement With Luminex 10
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 11
Genetic Analysis Enters into Agreement with Luminex 12
Luminex Enters into Distribution Agreement with Bio-Techne 13
Affymetrix Enters into Distribution Agreement with Luminex 14
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 15
Luminex Extends Distribution Agreement With EMD Millipore 16
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 17
Luminex Plans To Sell Newborn Screening Business 18
Luminex Acquires Nanosphere in Tender Offer 19
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto USD60 Million 21
Luminex Corp, Key Competitors 23
Luminex Corp, Key Employees 24
Luminex Corp, Other Locations 25
Luminex Corp, Subsidiaries 25

List of Figures
Luminex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Luminex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Luminex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Luminex Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Luminex Corp (LMNX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PT MultiIntegra:企業の戦略・SWOT・財務情報
    PT MultiIntegra - Strategy, SWOT and Corporate Finance Report Summary PT MultiIntegra - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Quest PharmaTech Inc (QPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • SEACOR Holdings Inc.:企業の戦略・SWOT・財務分析
    SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ten Network Holdings Ltd:企業の戦略的SWOT分析
    Ten Network Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • WESCO International Inc (WCC):企業の財務・戦略的SWOT分析
    WESCO International Inc (WCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • EVN AG:企業の発電所・SWOT分析2018
    EVN AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Can-Pack S.A.:企業の戦略・SWOT・財務情報
    Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report Summary Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • TriWest Healthcare Alliance Corp:企業の戦略的SWOT分析
    TriWest Healthcare Alliance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) discovers and develops antibody therapeutics for cancer indications. The company is investigating MCLA-128, for the treatment of metastatic breast cancer and solid tumors; MCLA-117 designed to harness and activate T-cells to kill CLEC12A-expressing acute myeloid leukemia (AM …
  • PetroMaroc Corporation Plc (PMA):企業の財務・戦略的SWOT分析
    Summary PetroMaroc Corporation Plc (Petromaroc), formerly Longreach Oil and Gas Ltd, is an oil and gas exploration and development company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company holds interests in the Sidi Moktar licence area which includes geo …
  • Key Energy Services, Inc. (KEG)-石油・ガス分野:企業M&A・提携分析
    Summary Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Active Biotech AB (ACTI)-製薬・医療分野:企業M&A・提携分析
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed o …
  • Northwest Territories Power Corp:企業の発電所・SWOT分析2018
    Northwest Territories Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆